nodes	percent_of_prediction	percent_of_DWPC	metapath
Clonidine—SLC6A2—autonomic nervous system—Gilles de la Tourette syndrome	0.0487	0.166	CbGeAlD
Clonidine—NISCH—midbrain—Gilles de la Tourette syndrome	0.0145	0.0496	CbGeAlD
Clonidine—SLC6A2—Na+/Cl- dependent neurotransmitter transporters—SLC6A3—Gilles de la Tourette syndrome	0.014	0.0198	CbGpPWpGaD
Clonidine—ADRA1D—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.0107	0.0151	CbGpPWpGaD
Clonidine—SLC22A1—Na+/Cl- dependent neurotransmitter transporters—SLC6A3—Gilles de la Tourette syndrome	0.0105	0.0149	CbGpPWpGaD
Clonidine—ADRA1B—nervous system—Gilles de la Tourette syndrome	0.0102	0.0348	CbGeAlD
Clonidine—ADRA1D—nervous system—Gilles de la Tourette syndrome	0.00998	0.034	CbGeAlD
Clonidine—ADRA1B—central nervous system—Gilles de la Tourette syndrome	0.00982	0.0335	CbGeAlD
Clonidine—SLC6A2—Amine compound SLC transporters—SLC6A3—Gilles de la Tourette syndrome	0.00973	0.0138	CbGpPWpGaD
Clonidine—ADRA2B—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.00964	0.0136	CbGpPWpGaD
Clonidine—ADRA1D—central nervous system—Gilles de la Tourette syndrome	0.00961	0.0327	CbGeAlD
Clonidine—SLC6A2—Monoamine Transport—SLC6A3—Gilles de la Tourette syndrome	0.00924	0.0131	CbGpPWpGaD
Clonidine—NISCH—brain—Gilles de la Tourette syndrome	0.00914	0.0311	CbGeAlD
Clonidine—ADRA1D—Monoamine GPCRs—DRD3—Gilles de la Tourette syndrome	0.0091	0.0129	CbGpPWpGaD
Clonidine—ADRA2C—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.009	0.0127	CbGpPWpGaD
Clonidine—ADRA1B—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.00886	0.0125	CbGpPWpGaD
Clonidine—ADRA1D—Monoamine GPCRs—DRD4—Gilles de la Tourette syndrome	0.00884	0.0125	CbGpPWpGaD
Clonidine—ADRA1D—Monoamine GPCRs—DRD2—Gilles de la Tourette syndrome	0.00823	0.0117	CbGpPWpGaD
Clonidine—ADRA2B—Monoamine GPCRs—DRD3—Gilles de la Tourette syndrome	0.00822	0.0116	CbGpPWpGaD
Clonidine—ADRA2B—Monoamine GPCRs—DRD4—Gilles de la Tourette syndrome	0.00798	0.0113	CbGpPWpGaD
Clonidine—ADRA1A—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.00787	0.0111	CbGpPWpGaD
Clonidine—ADRA1B—brain—Gilles de la Tourette syndrome	0.0078	0.0266	CbGeAlD
Clonidine—ADRA2C—Monoamine GPCRs—DRD3—Gilles de la Tourette syndrome	0.00768	0.0109	CbGpPWpGaD
Clonidine—ADRA1D—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.00765	0.0108	CbGpPWpGaD
Clonidine—ADRA1D—brain—Gilles de la Tourette syndrome	0.00763	0.026	CbGeAlD
Clonidine—ADRA1B—Monoamine GPCRs—DRD3—Gilles de la Tourette syndrome	0.00756	0.0107	CbGpPWpGaD
Clonidine—SLC22A1—nervous system—Gilles de la Tourette syndrome	0.00753	0.0257	CbGeAlD
Clonidine—ADRA2C—Monoamine GPCRs—DRD4—Gilles de la Tourette syndrome	0.00745	0.0105	CbGpPWpGaD
Clonidine—ADRA2B—Monoamine GPCRs—DRD2—Gilles de la Tourette syndrome	0.00743	0.0105	CbGpPWpGaD
Clonidine—ADRA1D—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.00743	0.0105	CbGpPWpGaD
Clonidine—ADRA1B—Monoamine GPCRs—DRD4—Gilles de la Tourette syndrome	0.00733	0.0104	CbGpPWpGaD
Clonidine—ADRA2A—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.00731	0.0103	CbGpPWpGaD
Clonidine—SLC22A1—Amine compound SLC transporters—SLC6A3—Gilles de la Tourette syndrome	0.00731	0.0103	CbGpPWpGaD
Clonidine—SLC22A1—central nervous system—Gilles de la Tourette syndrome	0.00725	0.0247	CbGeAlD
Clonidine—SLC22A3—nervous system—Gilles de la Tourette syndrome	0.00719	0.0245	CbGeAlD
Clonidine—ADRA2C—Monoamine GPCRs—DRD2—Gilles de la Tourette syndrome	0.00694	0.00983	CbGpPWpGaD
Clonidine—SLC22A3—central nervous system—Gilles de la Tourette syndrome	0.00693	0.0236	CbGeAlD
Clonidine—ADRA1D—Amine ligand-binding receptors—DRD2—Gilles de la Tourette syndrome	0.00692	0.00979	CbGpPWpGaD
Clonidine—ADRA2B—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.00691	0.00978	CbGpPWpGaD
Clonidine—ADRA1B—Monoamine GPCRs—DRD2—Gilles de la Tourette syndrome	0.00683	0.00967	CbGpPWpGaD
Clonidine—ADRA1A—Monoamine GPCRs—DRD3—Gilles de la Tourette syndrome	0.00671	0.0095	CbGpPWpGaD
Clonidine—ADRA2B—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.00671	0.00949	CbGpPWpGaD
Clonidine—ADRA2C—midbrain—Gilles de la Tourette syndrome	0.00664	0.0226	CbGeAlD
Clonidine—ADRA1A—Monoamine GPCRs—DRD4—Gilles de la Tourette syndrome	0.00652	0.00922	CbGpPWpGaD
Clonidine—SLC22A4—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A3—Gilles de la Tourette syndrome	0.00648	0.00917	CbGpPWpGaD
Clonidine—ADRA2C—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.00645	0.00913	CbGpPWpGaD
Clonidine—SLC22A5—midbrain—Gilles de la Tourette syndrome	0.00636	0.0217	CbGeAlD
Clonidine—ADRA1B—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.00635	0.00899	CbGpPWpGaD
Clonidine—ADRA2C—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.00626	0.00887	CbGpPWpGaD
Clonidine—ADRA2B—Amine ligand-binding receptors—DRD2—Gilles de la Tourette syndrome	0.00625	0.00884	CbGpPWpGaD
Clonidine—ADRA2A—Monoamine GPCRs—DRD3—Gilles de la Tourette syndrome	0.00624	0.00882	CbGpPWpGaD
Clonidine—ADRA1B—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.00617	0.00873	CbGpPWpGaD
Clonidine—SLC6A2—nervous system—Gilles de la Tourette syndrome	0.00616	0.021	CbGeAlD
Clonidine—ADRA1A—Monoamine GPCRs—DRD2—Gilles de la Tourette syndrome	0.00607	0.00859	CbGpPWpGaD
Clonidine—ADRA2A—Monoamine GPCRs—DRD4—Gilles de la Tourette syndrome	0.00605	0.00857	CbGpPWpGaD
Clonidine—SLC22A4—brain—Gilles de la Tourette syndrome	0.00604	0.0206	CbGeAlD
Clonidine—SLC6A2—central nervous system—Gilles de la Tourette syndrome	0.00593	0.0202	CbGeAlD
Clonidine—ADRA2C—Amine ligand-binding receptors—DRD2—Gilles de la Tourette syndrome	0.00584	0.00826	CbGpPWpGaD
Clonidine—ADRA1D—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.00577	0.00816	CbGpPWpGaD
Clonidine—SLC22A1—brain—Gilles de la Tourette syndrome	0.00575	0.0196	CbGeAlD
Clonidine—ADRA1B—Amine ligand-binding receptors—DRD2—Gilles de la Tourette syndrome	0.00574	0.00813	CbGpPWpGaD
Clonidine—ADRA1A—nervous system—Gilles de la Tourette syndrome	0.00573	0.0195	CbGeAlD
Clonidine—ADRA1A—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.00564	0.00798	CbGpPWpGaD
Clonidine—ADRA2A—Monoamine GPCRs—DRD2—Gilles de la Tourette syndrome	0.00564	0.00798	CbGpPWpGaD
Clonidine—ADRA1A—central nervous system—Gilles de la Tourette syndrome	0.00552	0.0188	CbGeAlD
Clonidine—SLC22A3—brain—Gilles de la Tourette syndrome	0.0055	0.0187	CbGeAlD
Clonidine—ADRA1A—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.00548	0.00775	CbGpPWpGaD
Clonidine—ADRA2C—nervous system—Gilles de la Tourette syndrome	0.00546	0.0186	CbGeAlD
Clonidine—ADRA2A—midbrain—Gilles de la Tourette syndrome	0.0053	0.0181	CbGeAlD
Clonidine—ADRA2C—central nervous system—Gilles de la Tourette syndrome	0.00526	0.0179	CbGeAlD
Clonidine—ADRA2A—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.00524	0.00742	CbGpPWpGaD
Clonidine—ADRA2B—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.00521	0.00737	CbGpPWpGaD
Clonidine—ADRA1A—Amine ligand-binding receptors—DRD2—Gilles de la Tourette syndrome	0.0051	0.00722	CbGpPWpGaD
Clonidine—ADRA2A—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.00509	0.0072	CbGpPWpGaD
Clonidine—SLC22A3—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A3—Gilles de la Tourette syndrome	0.00489	0.00692	CbGpPWpGaD
Clonidine—SLC22A5—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A3—Gilles de la Tourette syndrome	0.00487	0.0069	CbGpPWpGaD
Clonidine—ADRA2C—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.00486	0.00688	CbGpPWpGaD
Clonidine—ADRA1D—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.00485	0.00686	CbGpPWpGaD
Clonidine—ADRA1B—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.00479	0.00677	CbGpPWpGaD
Clonidine—ADRA2A—Amine ligand-binding receptors—DRD2—Gilles de la Tourette syndrome	0.00474	0.00671	CbGpPWpGaD
Clonidine—SLC6A2—brain—Gilles de la Tourette syndrome	0.00471	0.0161	CbGeAlD
Clonidine—CYP1A1—nervous system—Gilles de la Tourette syndrome	0.00467	0.0159	CbGeAlD
Clonidine—CYP1A1—central nervous system—Gilles de la Tourette syndrome	0.0045	0.0153	CbGeAlD
Clonidine—ADRA1A—brain—Gilles de la Tourette syndrome	0.00438	0.0149	CbGeAlD
Clonidine—ADRA2B—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.00438	0.00619	CbGpPWpGaD
Clonidine—ADRA2A—nervous system—Gilles de la Tourette syndrome	0.00436	0.0149	CbGeAlD
Clonidine—ADRA1A—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.00425	0.00602	CbGpPWpGaD
Clonidine—ADRA2A—central nervous system—Gilles de la Tourette syndrome	0.0042	0.0143	CbGeAlD
Clonidine—ADRA2C—brain—Gilles de la Tourette syndrome	0.00417	0.0142	CbGeAlD
Clonidine—ADRA2C—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.00409	0.00578	CbGpPWpGaD
Clonidine—ADRA1D—GPCRs, Other—DRD3—Gilles de la Tourette syndrome	0.00404	0.00572	CbGpPWpGaD
Clonidine—ADRA1B—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.00402	0.00569	CbGpPWpGaD
Clonidine—SLC22A5—brain—Gilles de la Tourette syndrome	0.004	0.0136	CbGeAlD
Clonidine—ADRA2A—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.00395	0.00559	CbGpPWpGaD
Clonidine—ADRA1D—GPCRs, Other—DRD4—Gilles de la Tourette syndrome	0.00393	0.00556	CbGpPWpGaD
Clonidine—SLC6A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A3—Gilles de la Tourette syndrome	0.0038	0.00538	CbGpPWpGaD
Clonidine—ADRA1A—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.00357	0.00506	CbGpPWpGaD
Clonidine—CYP1A1—brain—Gilles de la Tourette syndrome	0.00357	0.0122	CbGeAlD
Clonidine—CYP3A4—nervous system—Gilles de la Tourette syndrome	0.00343	0.0117	CbGeAlD
Clonidine—CYP2D6—nervous system—Gilles de la Tourette syndrome	0.00338	0.0115	CbGeAlD
Clonidine—ADRA2A—brain—Gilles de la Tourette syndrome	0.00333	0.0114	CbGeAlD
Clonidine—ADRA2A—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.00332	0.0047	CbGpPWpGaD
Clonidine—CYP3A4—central nervous system—Gilles de la Tourette syndrome	0.0033	0.0113	CbGeAlD
Clonidine—CYP2D6—central nervous system—Gilles de la Tourette syndrome	0.00325	0.0111	CbGeAlD
Clonidine—ABCB1—midbrain—Gilles de la Tourette syndrome	0.00295	0.0101	CbGeAlD
Clonidine—SLC22A4—SLC-mediated transmembrane transport—SLC6A3—Gilles de la Tourette syndrome	0.00295	0.00417	CbGpPWpGaD
Clonidine—SLC22A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A3—Gilles de la Tourette syndrome	0.00286	0.00404	CbGpPWpGaD
Clonidine—SLC6A2—NRF2 pathway—SLC6A3—Gilles de la Tourette syndrome	0.00274	0.00388	CbGpPWpGaD
Clonidine—CYP2D6—brain—Gilles de la Tourette syndrome	0.00258	0.00879	CbGeAlD
Clonidine—ADRA1D—GPCRs, Other—HTR2A—Gilles de la Tourette syndrome	0.00256	0.00362	CbGpPWpGaD
Clonidine—ABCB1—nervous system—Gilles de la Tourette syndrome	0.00243	0.00828	CbGeAlD
Clonidine—ABCB1—central nervous system—Gilles de la Tourette syndrome	0.00234	0.00797	CbGeAlD
Clonidine—SLC22A3—SLC-mediated transmembrane transport—SLC6A3—Gilles de la Tourette syndrome	0.00222	0.00314	CbGpPWpGaD
Clonidine—SLC22A5—SLC-mediated transmembrane transport—SLC6A3—Gilles de la Tourette syndrome	0.00221	0.00313	CbGpPWpGaD
Clonidine—ABCB1—brain—Gilles de la Tourette syndrome	0.00186	0.00633	CbGeAlD
Clonidine—ADRA1D—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.00176	0.00249	CbGpPWpGaD
Clonidine—SLC6A2—SLC-mediated transmembrane transport—SLC6A3—Gilles de la Tourette syndrome	0.00173	0.00245	CbGpPWpGaD
Clonidine—ADRA2B—G alpha (i) signalling events—DRD3—Gilles de la Tourette syndrome	0.00171	0.00242	CbGpPWpGaD
Clonidine—ADRA1D—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.00171	0.00241	CbGpPWpGaD
Clonidine—ADRA2B—G alpha (i) signalling events—DRD4—Gilles de la Tourette syndrome	0.00166	0.00235	CbGpPWpGaD
Clonidine—SLC22A1—Transmission across Chemical Synapses—SLC6A3—Gilles de la Tourette syndrome	0.0016	0.00227	CbGpPWpGaD
Clonidine—ADRA2C—G alpha (i) signalling events—DRD3—Gilles de la Tourette syndrome	0.0016	0.00226	CbGpPWpGaD
Clonidine—ADRA1D—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.00159	0.00225	CbGpPWpGaD
Clonidine—ADRA2B—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.00159	0.00224	CbGpPWpGaD
Clonidine—ADRA2C—G alpha (i) signalling events—DRD4—Gilles de la Tourette syndrome	0.00155	0.00219	CbGpPWpGaD
Clonidine—ADRA2B—G alpha (i) signalling events—DRD2—Gilles de la Tourette syndrome	0.00155	0.00219	CbGpPWpGaD
Clonidine—ADRA2B—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.00154	0.00218	CbGpPWpGaD
Clonidine—SLC22A3—Metabolism—HDC—Gilles de la Tourette syndrome	0.00152	0.00215	CbGpPWpGaD
Clonidine—ADRA1D—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.00151	0.00213	CbGpPWpGaD
Clonidine—SLC22A4—Transmembrane transport of small molecules—SLC6A3—Gilles de la Tourette syndrome	0.0015	0.00212	CbGpPWpGaD
Clonidine—ADRA2C—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.00148	0.0021	CbGpPWpGaD
Clonidine—ADRA1D—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.00146	0.00207	CbGpPWpGaD
Clonidine—ADRA1B—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.00146	0.00206	CbGpPWpGaD
Clonidine—ADRA2C—G alpha (i) signalling events—DRD2—Gilles de la Tourette syndrome	0.00144	0.00204	CbGpPWpGaD
Clonidine—ADRA1D—G alpha (q) signalling events—HTR2A—Gilles de la Tourette syndrome	0.00144	0.00204	CbGpPWpGaD
Clonidine—ADRA2C—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.00144	0.00204	CbGpPWpGaD
Clonidine—ADRA2B—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.00143	0.00203	CbGpPWpGaD
Clonidine—ADRA1B—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.00142	0.002	CbGpPWpGaD
Clonidine—ADRA1D—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.00136	0.00193	CbGpPWpGaD
Clonidine—ADRA2B—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.00136	0.00192	CbGpPWpGaD
Clonidine—ADRA2C—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.00134	0.0019	CbGpPWpGaD
Clonidine—ADRA2B—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.00132	0.00187	CbGpPWpGaD
Clonidine—ADRA1B—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.00132	0.00187	CbGpPWpGaD
Clonidine—SLC22A1—SLC-mediated transmembrane transport—SLC6A3—Gilles de la Tourette syndrome	0.0013	0.00184	CbGpPWpGaD
Clonidine—ADRA2A—G alpha (i) signalling events—DRD3—Gilles de la Tourette syndrome	0.0013	0.00184	CbGpPWpGaD
Clonidine—ADRA1A—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.0013	0.00183	CbGpPWpGaD
Clonidine—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Gilles de la Tourette syndrome	0.00129	0.00182	CbGpPWpGaD
Clonidine—ADRA2C—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.00127	0.0018	CbGpPWpGaD
Clonidine—ADRA2A—G alpha (i) signalling events—DRD4—Gilles de la Tourette syndrome	0.00126	0.00178	CbGpPWpGaD
Clonidine—ADRA1A—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.00126	0.00178	CbGpPWpGaD
Clonidine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.00125	0.00177	CbGpPWpGaD
Clonidine—ADRA2C—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.00123	0.00174	CbGpPWpGaD
Clonidine—ADRA2B—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.00123	0.00174	CbGpPWpGaD
Clonidine—SLC22A1—Neuronal System—SLC6A3—Gilles de la Tourette syndrome	0.00123	0.00174	CbGpPWpGaD
Clonidine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.00121	0.00172	CbGpPWpGaD
Clonidine—ADRA2A—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.0012	0.0017	CbGpPWpGaD
Clonidine—ADRA1B—G alpha (q) signalling events—HTR2A—Gilles de la Tourette syndrome	0.00119	0.00169	CbGpPWpGaD
Clonidine—ADRA2A—G alpha (i) signalling events—DRD2—Gilles de la Tourette syndrome	0.00117	0.00166	CbGpPWpGaD
Clonidine—ADRA1A—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.00117	0.00166	CbGpPWpGaD
Clonidine—ADRA2A—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.00117	0.00165	CbGpPWpGaD
Clonidine—ADRA2C—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.00115	0.00162	CbGpPWpGaD
Clonidine—ADRA1D—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.00115	0.00162	CbGpPWpGaD
Clonidine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.00113	0.0016	CbGpPWpGaD
Clonidine—SLC22A3—Transmembrane transport of small molecules—SLC6A3—Gilles de la Tourette syndrome	0.00113	0.0016	CbGpPWpGaD
Clonidine—SLC22A5—Transmembrane transport of small molecules—SLC6A3—Gilles de la Tourette syndrome	0.00113	0.00159	CbGpPWpGaD
Clonidine—ADRA1D—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.00111	0.00157	CbGpPWpGaD
Clonidine—ADRA1D—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.00111	0.00157	CbGpPWpGaD
Clonidine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.00111	0.00157	CbGpPWpGaD
Clonidine—ADRA2A—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.00109	0.00154	CbGpPWpGaD
Clonidine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.00108	0.00152	CbGpPWpGaD
Clonidine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Gilles de la Tourette syndrome	0.00107	0.00151	CbGpPWpGaD
Clonidine—ADRA1A—G alpha (q) signalling events—HTR2A—Gilles de la Tourette syndrome	0.00106	0.0015	CbGpPWpGaD
Clonidine—ADRA1D—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.00104	0.00147	CbGpPWpGaD
Clonidine—ADRA2B—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.00103	0.00146	CbGpPWpGaD
Clonidine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.00103	0.00146	CbGpPWpGaD
Clonidine—ADRA2B—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.001	0.00142	CbGpPWpGaD
Clonidine—ADRA2B—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.001	0.00142	CbGpPWpGaD
Clonidine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.001	0.00142	CbGpPWpGaD
Clonidine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.001	0.00142	CbGpPWpGaD
Clonidine—ADRA2C—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.000967	0.00137	CbGpPWpGaD
Clonidine—ADRA1D—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.000953	0.00135	CbGpPWpGaD
Clonidine—ADRA1B—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.000951	0.00135	CbGpPWpGaD
Clonidine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Gilles de la Tourette syndrome	0.000949	0.00134	CbGpPWpGaD
Clonidine—ADRA2C—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.000938	0.00133	CbGpPWpGaD
Clonidine—ADRA2C—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.000938	0.00133	CbGpPWpGaD
Clonidine—ADRA2B—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.000936	0.00132	CbGpPWpGaD
Clonidine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.000932	0.00132	CbGpPWpGaD
Clonidine—ADRA2C—Metabolism—HDC—Gilles de la Tourette syndrome	0.000927	0.00131	CbGpPWpGaD
Clonidine—ADRA1B—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.000924	0.00131	CbGpPWpGaD
Clonidine—ADRA1B—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.000924	0.00131	CbGpPWpGaD
Clonidine—SLC22A1—Metabolism—HDC—Gilles de la Tourette syndrome	0.000888	0.00126	CbGpPWpGaD
Clonidine—SLC6A2—Transmembrane transport of small molecules—SLC6A3—Gilles de la Tourette syndrome	0.000878	0.00124	CbGpPWpGaD
Clonidine—ADRA2C—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.000874	0.00124	CbGpPWpGaD
Clonidine—ADRA2B—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.000861	0.00122	CbGpPWpGaD
Clonidine—ADRA1B—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.00086	0.00122	CbGpPWpGaD
Clonidine—ADRA1A—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.000845	0.0012	CbGpPWpGaD
Clonidine—ADRA1A—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.00082	0.00116	CbGpPWpGaD
Clonidine—ADRA1A—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.00082	0.00116	CbGpPWpGaD
Clonidine—ADRA2C—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.000804	0.00114	CbGpPWpGaD
Clonidine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.000791	0.00112	CbGpPWpGaD
Clonidine—ADRA2A—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.000785	0.00111	CbGpPWpGaD
Clonidine—ADRA1A—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.000764	0.00108	CbGpPWpGaD
Clonidine—ADRA2A—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.000762	0.00108	CbGpPWpGaD
Clonidine—ADRA2A—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.000762	0.00108	CbGpPWpGaD
Clonidine—ADRA2A—Metabolism—HDC—Gilles de la Tourette syndrome	0.000753	0.00107	CbGpPWpGaD
Clonidine—ADRA1D—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.000726	0.00103	CbGpPWpGaD
Clonidine—ADRA2A—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.00071	0.001	CbGpPWpGaD
Clonidine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.000703	0.000995	CbGpPWpGaD
Clonidine—CYP3A5—Metabolism—HDC—Gilles de la Tourette syndrome	0.00069	0.000976	CbGpPWpGaD
Clonidine—SLC22A1—Transmembrane transport of small molecules—SLC6A3—Gilles de la Tourette syndrome	0.00066	0.000934	CbGpPWpGaD
Clonidine—ADRA2B—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.000655	0.000928	CbGpPWpGaD
Clonidine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.000653	0.000924	CbGpPWpGaD
Clonidine—CYP1A1—Metabolism—HDC—Gilles de la Tourette syndrome	0.000652	0.000922	CbGpPWpGaD
Clonidine—ADRA1D—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.000648	0.000917	CbGpPWpGaD
Clonidine—ADRA1D—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.000629	0.00089	CbGpPWpGaD
Clonidine—ADRA2C—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.000612	0.000866	CbGpPWpGaD
Clonidine—ADRA1B—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.000603	0.000853	CbGpPWpGaD
Clonidine—ADRA1D—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.000588	0.000832	CbGpPWpGaD
Clonidine—ADRA1D—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.000586	0.000829	CbGpPWpGaD
Clonidine—ADRA2B—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.000585	0.000828	CbGpPWpGaD
Clonidine—ADRA1D—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.000571	0.000808	CbGpPWpGaD
Clonidine—ADRA2B—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.000568	0.000803	CbGpPWpGaD
Clonidine—ADRA2C—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.000546	0.000773	CbGpPWpGaD
Clonidine—ADRA1B—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.000538	0.000761	CbGpPWpGaD
Clonidine—ADRA1A—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.000535	0.000757	CbGpPWpGaD
Clonidine—ADRA1D—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.000532	0.000753	CbGpPWpGaD
Clonidine—ADRA2B—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.000531	0.000752	CbGpPWpGaD
Clonidine—ADRA2C—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.00053	0.00075	CbGpPWpGaD
Clonidine—ADRA2B—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.000529	0.000748	CbGpPWpGaD
Clonidine—ADRA1B—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.000522	0.000739	CbGpPWpGaD
Clonidine—ABCB1—Metabolism—HDC—Gilles de la Tourette syndrome	0.000521	0.000737	CbGpPWpGaD
Clonidine—ADRA2B—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.000516	0.00073	CbGpPWpGaD
Clonidine—ADRA2A—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.000497	0.000704	CbGpPWpGaD
Clonidine—ADRA2C—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.000496	0.000702	CbGpPWpGaD
Clonidine—ADRA2C—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.000494	0.000699	CbGpPWpGaD
Clonidine—CYP2D6—Metabolism—HDC—Gilles de la Tourette syndrome	0.000491	0.000694	CbGpPWpGaD
Clonidine—ADRA1B—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.000488	0.000691	CbGpPWpGaD
Clonidine—ADRA1B—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.000486	0.000688	CbGpPWpGaD
Clonidine—ADRA2C—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.000482	0.000682	CbGpPWpGaD
Clonidine—ADRA2B—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.00048	0.00068	CbGpPWpGaD
Clonidine—ADRA1A—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.000478	0.000676	CbGpPWpGaD
Clonidine—ADRA1B—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.000474	0.000671	CbGpPWpGaD
Clonidine—ADRA1A—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.000464	0.000656	CbGpPWpGaD
Clonidine—ADRA2C—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.000449	0.000635	CbGpPWpGaD
Clonidine—ADRA2A—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.000444	0.000628	CbGpPWpGaD
Clonidine—ADRA1B—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.000442	0.000625	CbGpPWpGaD
Clonidine—ADRA1A—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.000434	0.000614	CbGpPWpGaD
Clonidine—ADRA1A—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.000432	0.000611	CbGpPWpGaD
Clonidine—ADRA2A—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.000431	0.00061	CbGpPWpGaD
Clonidine—ADRA1A—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.000421	0.000596	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—HDC—Gilles de la Tourette syndrome	0.000416	0.000588	CbGpPWpGaD
Clonidine—ADRA1D—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.00041	0.000581	CbGpPWpGaD
Clonidine—ADRA2A—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.000403	0.00057	CbGpPWpGaD
Clonidine—ADRA2A—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.000401	0.000568	CbGpPWpGaD
Clonidine—ADRA1A—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.000392	0.000555	CbGpPWpGaD
Clonidine—ADRA2A—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.000391	0.000554	CbGpPWpGaD
Clonidine—ABCB1—Transmembrane transport of small molecules—SLC6A3—Gilles de la Tourette syndrome	0.000387	0.000547	CbGpPWpGaD
Clonidine—ADRA1D—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.000373	0.000527	CbGpPWpGaD
Clonidine—ADRA2B—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.00037	0.000524	CbGpPWpGaD
Clonidine—ADRA2A—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.000364	0.000516	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.000347	0.000492	CbGpPWpGaD
Clonidine—ADRA2C—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.000346	0.00049	CbGpPWpGaD
Clonidine—ADRA1B—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.000341	0.000482	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.000337	0.000477	CbGpPWpGaD
Clonidine—ADRA2B—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.000336	0.000476	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—HDC—Gilles de la Tourette syndrome	0.000321	0.000454	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.000314	0.000445	CbGpPWpGaD
Clonidine—ADRA2C—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.000314	0.000445	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.000314	0.000444	CbGpPWpGaD
Clonidine—ADRA1B—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.000309	0.000438	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.000305	0.000431	CbGpPWpGaD
Clonidine—ADRA1A—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.000302	0.000428	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.000293	0.000415	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.000288	0.000408	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.000284	0.000403	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.000284	0.000401	CbGpPWpGaD
Clonidine—ADRA2A—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.000281	0.000398	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.00028	0.000396	CbGpPWpGaD
Clonidine—ADRA1A—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.000275	0.000389	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.000265	0.000375	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.000261	0.000369	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.000256	0.000363	CbGpPWpGaD
Clonidine—ADRA2A—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.000255	0.000361	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.000249	0.000352	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.000238	0.000337	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.000232	0.000328	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.000231	0.000327	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.00022	0.000311	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.000215	0.000305	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.000199	0.000281	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.000186	0.000263	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.000183	0.000259	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.000162	0.00023	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.000151	0.000213	CbGpPWpGaD
